BE836151A - Nouvel ester de la 19-nor-testosterone et son application comme medicament anabolique - Google Patents
Nouvel ester de la 19-nor-testosterone et son application comme medicament anaboliqueInfo
- Publication number
- BE836151A BE836151A BE162338A BE162338A BE836151A BE 836151 A BE836151 A BE 836151A BE 162338 A BE162338 A BE 162338A BE 162338 A BE162338 A BE 162338A BE 836151 A BE836151 A BE 836151A
- Authority
- BE
- Belgium
- Prior art keywords
- new
- application
- testosterone ester
- anabolic drug
- anabolic
- Prior art date
Links
- 239000003263 anabolic agent Substances 0.000 title 1
- 229960004719 nandrolone Drugs 0.000 title 1
- NPAGDVCDWIYMMC-IZPLOLCNSA-N nandrolone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 NPAGDVCDWIYMMC-IZPLOLCNSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
- C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
- C07J1/0074—Esters
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL7415669A NL7415669A (nl) | 1974-12-02 | 1974-12-02 | Werkwijze ter bereiding van een nieuwe ester van 19-nor-testosteron. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE836151A true BE836151A (fr) | 1976-06-01 |
Family
ID=19822576
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE162338A BE836151A (fr) | 1974-12-02 | 1975-12-01 | Nouvel ester de la 19-nor-testosterone et son application comme medicament anabolique |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4002747A (is") |
| JP (1) | JPS5182252A (is") |
| AU (1) | AU500934B2 (is") |
| BE (1) | BE836151A (is") |
| CA (1) | CA1044224A (is") |
| CH (1) | CH616689A5 (is") |
| DE (1) | DE2553997A1 (is") |
| DK (1) | DK135456B (is") |
| ES (1) | ES443115A1 (is") |
| FI (1) | FI54129C (is") |
| FR (1) | FR2293210A1 (is") |
| GB (1) | GB1534147A (is") |
| HU (1) | HU170931B (is") |
| IE (1) | IE42139B1 (is") |
| LU (1) | LU73894A1 (is") |
| NL (1) | NL7415669A (is") |
| SE (1) | SE404529B (is") |
| ZA (1) | ZA757352B (is") |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0573848T3 (da) * | 1992-06-12 | 1998-08-10 | Hoechst Ag | Galdesyrederivater, fremgangsmåde til deres fremstilling og anvendelse af disse forbindelser som lægemidler |
| CA2553815A1 (en) * | 2004-01-15 | 2005-08-04 | Warner Chilcott Company, Inc. | Di-steroidal prodrugs of estradiol |
| WO2005070950A1 (en) * | 2004-01-15 | 2005-08-04 | Warner Chilcott Company, Inc. | Di-steroidal prodrugs of ethinyl estradiol |
| CA2610481A1 (en) * | 2005-07-12 | 2007-01-18 | Warner Chilcott Company, Inc. | 3-ester prodrugs of estradiol |
| WO2007024338A2 (en) * | 2005-07-12 | 2007-03-01 | Warner Chilcott Company, Inc. | 3 -ester prodrugs of ethynylestradiol |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL147740B (nl) * | 1965-10-28 | 1975-11-17 | Organon Nv | Werkwijze ter bereiding van dicarbonzuuresters van 19-nor-testosteron met verlengde anabole werking, alsmede gevormd farmaceutisch preparaat. |
-
1974
- 1974-12-02 NL NL7415669A patent/NL7415669A/xx not_active Application Discontinuation
-
1975
- 1975-11-24 US US05/634,391 patent/US4002747A/en not_active Expired - Lifetime
- 1975-11-24 IE IE2547/75A patent/IE42139B1/en unknown
- 1975-11-24 ZA ZA757352A patent/ZA757352B/xx unknown
- 1975-11-26 GB GB48639/75A patent/GB1534147A/en not_active Expired
- 1975-11-26 AU AU86965/75A patent/AU500934B2/en not_active Expired
- 1975-11-26 CH CH1534275A patent/CH616689A5/de not_active IP Right Cessation
- 1975-11-28 FI FI753372A patent/FI54129C/fi not_active IP Right Cessation
- 1975-11-28 LU LU73894A patent/LU73894A1/xx unknown
- 1975-11-28 JP JP50143281A patent/JPS5182252A/ja active Pending
- 1975-12-01 FR FR7536719A patent/FR2293210A1/fr active Granted
- 1975-12-01 ES ES443115A patent/ES443115A1/es not_active Expired
- 1975-12-01 CA CA240,847A patent/CA1044224A/en not_active Expired
- 1975-12-01 BE BE162338A patent/BE836151A/xx unknown
- 1975-12-01 DK DK540675AA patent/DK135456B/da unknown
- 1975-12-01 SE SE7513497A patent/SE404529B/xx unknown
- 1975-12-01 DE DE19752553997 patent/DE2553997A1/de not_active Withdrawn
- 1975-12-02 HU HU75AO00000430A patent/HU170931B/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HU170931B (hu) | 1977-10-28 |
| AU500934B2 (en) | 1979-06-07 |
| FI753372A7 (is") | 1976-06-03 |
| JPS5182252A (en) | 1976-07-19 |
| NL7415669A (nl) | 1976-06-04 |
| FR2293210A1 (fr) | 1976-07-02 |
| ZA757352B (en) | 1976-11-24 |
| DE2553997A1 (de) | 1976-08-12 |
| GB1534147A (en) | 1978-11-29 |
| FR2293210B1 (is") | 1979-09-21 |
| SE404529B (sv) | 1978-10-09 |
| AU8696575A (en) | 1977-06-02 |
| DK540675A (is") | 1976-06-03 |
| FI54129B (fi) | 1978-06-30 |
| CA1044224A (en) | 1978-12-12 |
| DK135456B (da) | 1977-05-02 |
| FI54129C (fi) | 1978-10-10 |
| IE42139B1 (en) | 1980-06-04 |
| LU73894A1 (is") | 1976-07-01 |
| CH616689A5 (is") | 1980-04-15 |
| SE7513497L (sv) | 1976-06-03 |
| DK135456C (is") | 1977-09-26 |
| US4002747A (en) | 1977-01-11 |
| IE42139L (en) | 1976-06-02 |
| ES443115A1 (es) | 1977-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2330387A1 (fr) | Nouveau compose peptidique, sa preparation et son application comme medicament | |
| IT1042731B (it) | Supporti per sostanze attive medicamentose | |
| FR2276832A1 (fr) | Nouvelles compositions pharmaceutiques et leur preparation | |
| IT1028944B (it) | Siringa dentistica | |
| BE828820A (fr) | Composition insecticide et son application | |
| FR2352808A1 (fr) | Acides 12-azaprostanoiques utiles comme medicaments | |
| NL7502314A (nl) | Bereiding van vinylestercopolymeerlatices. | |
| BE832921A (fr) | Nouvelles rifamycines et leur preparation | |
| FR2313347A1 (fr) | Esters de l'acide 2,2-dimethyl-3,5,5,5-tetrachloropentane-1-carboxylique, leur preparation et leur application | |
| BE810854A (fr) | Esters de partricine et de derives de partricine | |
| FR2295955A1 (fr) | Derives morpholoniques et leur application comme fongicides | |
| BE836151A (fr) | Nouvel ester de la 19-nor-testosterone et son application comme medicament anabolique | |
| FR2274318A1 (fr) | Seringue hypodermique | |
| FR2277582A1 (fr) | Esters dialkylaminoalkyliques de penicilline, leur procede de preparation et leur application | |
| IT1050270B (it) | Esteri benzofuranilici sostituiti | |
| BR7506336A (pt) | Seringa | |
| BE826925A (fr) | Nouvelles pyrrolodiazepines et leur preparation | |
| FR2322594A1 (fr) | Nouvelles 2,3-trans-methylene-15-hydroxy-prostaglandines, leur preparation et leur application comme medicaments | |
| FR2453147B1 (fr) | Ester sulfosuccinique et son procede de preparation | |
| IT1050744B (it) | Composizione insetticida contenente esteri preparazione e impiego relativi | |
| BE833096A (fr) | Dissocyanato-dicetenes et leur preparation | |
| MC1098A1 (fr) | Composition photopolymerisable et son application | |
| BE867703A (fr) | Esters du type acetate, leur preparation et compositions pharmaceutiques en contenant | |
| BE825760R (fr) | Acides 4-amino-1,8-naphtalimide-3-sulfoniques et leur preparation | |
| BE843810A (fr) | Derives de 2-benzopyranone et leur application comme medicaments |